Coumermycin A1 is an aminocoumarin. Its main target is the ATPase site of the DNA gyrase GyrB subunit. It was developed in the early 1960's by Bristol Myers Squibb.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.